The PE Exit Readiness Playbook: How to Diligence Your Own Portfolio for 2026 Exits

The private equity industry is sitting on a backlog of roughly 33,000 portfolio companies worth an estimated $3.7 trillion, according to Bain & Company. More than 11,000 of those have been held for over five years. The average holding period has stretched to 6.6 years — well above the 6.1-year average observed between 2011 and 2020. At the current pace of exits, PitchBook estimates it would take eight years to clear the inventory.

The pressure to transact is building from every direction. Some 73% of PE firms now expect exit deals to increase over the next six months — the highest reading since the EY PE Pulse survey began. PE fundraising fell approximately 22% year-on-year in 2025, making strong distributions critical for firms planning to hit the fundraising trail in the next 6–12 months. DPI is the metric LPs care about, and DPI requires exits.

Meanwhile, 2025 showed that the market can move: global PE deal values surged 57%, and total exit value rebounded 41% compared with 2024 — though exit count actually fell 15%, underscoring that larger, higher-quality assets are trading while the long tail waits. Q1 2026 held its own at 975 exits totaling $306.7 billion.

Many market participants now see 2026 as the year exits normalise rather than merely rebound. But with thousands of sponsors simultaneously preparing assets for sale, competition among sellers will be fierce. The firms that win won't be the ones with the best assets — they'll be the ones with the best-prepared assets.

This guide is a practical playbook for PE deal teams who want to stress-test their own portfolio companies with the same rigour they apply to buy-side due diligence — and use primary research to build an exit case that withstands buyer scrutiny.

Why Most Exit Readiness Falls Short

Exit readiness is not a new concept. In fact, 88% of PE firms report undertaking targeted exit readiness activities during an asset's hold period, according to EY's 2025 Exit Readiness Study. So why do so many exits still stumble in diligence?

Because most exit prep is dangerously lopsided.

The financial readiness trap

For most firms, "exit readiness" means quality of earnings work, EBITDA adjustments, and getting the financials audit-ready. This is necessary but nowhere near sufficient. Almost 72% of firms identify weak data and KPI reporting as the biggest finance issue at exit. Two-thirds (65%) struggle to reflect value creation initiatives accurately in reported EBITDA, and 41% lack the data granularity to substantiate their equity stories.

Financial clean-up is table stakes. It doesn't differentiate your asset or pre-empt the questions a buyer's commercial due diligence team will ask.

The sponsor–CFO disconnect

There's a fundamental misalignment between how sponsors and CFOs define "exit-ready." Some 97% of sponsors expect CFOs to maintain an "always exit-ready" posture. Only 20% of CFOs say they actually operate that way. The majority — 61% — shift into exit mode only when a sale window appears.

That compressed sprint carries a real cost: sponsors report that late exit preparation can reduce valuation by 1–3 turns of exit multiple. Meanwhile, 63% of sponsors cite a CFO without prior exit experience as a top finance-function challenge, and 72% believe their portfolio company CFOs are underperforming on exit readiness and value optimisation.

The commercial blind spot

Here's the gap that matters most — and the one that's most consistently neglected. PE firms know their companies' financials inside and out. What they often lack is independent, externally validated evidence about:

• How customers actually perceive the business (not what management reports)
• How the competitive landscape has shifted since acquisition
• Whether the growth narrative holds up when tested against real market data
• What a buyer's commercial due diligence advisor will flag

Exit narratives are routinely built on management claims rather than independently validated data points — NPS scores, verified churn reasons, win/loss ratios confirmed through third-party research. Buyers know this, and in a market shaped by geopolitical and economic uncertainty, they're more cautious than ever. They want a clear, credible, and detailed view of how a business creates value. Without it, they will either discount the asset or walk away entirely.

Strategic buyers, PE sponsors, and IPO investors have all tightened diligence standards after sluggish exit years and a high-rate environment. Sellers who can pre-empt this scrutiny with their own rigorous commercial evidence hold a meaningful advantage.

The Exit Readiness Assessment Framework

Effective exit readiness spans four dimensions. Most firms have the first two covered. The third — commercial readiness — is where the biggest gap exists, and where the highest return on preparation time sits.

1. Financial readiness

This covers quality of earnings, EBITDA bridge, adjustments, carve-out accounting where relevant, and clean audit trails. It's the most established discipline and the most well-served by advisory firms. If your QoE isn't buttoned up 12+ months before exit, you're already behind.

Key question: Can you walk a buyer through every material EBITDA adjustment with supporting documentation?

2. Operational readiness

Systems, controls, processes, IT infrastructure, and — critically — the management team. Buyers evaluate whether the business can operate independently post-close, whether key-person risk exists, and whether operational processes are scalable.

Key question: If you removed the top three executives tomorrow, would the business keep running at the same level for six months?

3. Commercial readiness (the underserved dimension)

This is the layer most exit-readiness programmes neglect, and it's the one buyers focus on most intensely. Commercial readiness means having independently validated evidence of:

• Customer health: Retention rates, satisfaction scores, expansion revenue, and switching intent — validated by talking to actual customers, not by reviewing management's internal dashboards
• Competitive positioning: Where the asset genuinely stands relative to peers on product, pricing, service, and market perception — based on external benchmarking, not internal conviction
• Revenue quality: Concentration risk, contract durability, organic vs. acquired growth, pricing power — stress-tested through channel checks and customer interviews
• Market dynamics: End-market growth, TAM/SAM validation, secular tailwinds or headwinds — confirmed through independent expert interviews rather than relying on the company's own market sizing

Key question: If a buyer commissioned a full commercial due diligence study on this asset tomorrow, what would they find that you haven't already identified and addressed?

4. Data readiness

An emerging but increasingly critical dimension. Good data readiness combines high-quality data, strong reporting capability, and clear alignment between operational metrics and financial outcomes. Growth through acquisition can leave data fragmented across systems, while limited operational transparency slows decision-making.

Notably, 85% of buyers now consider AI-enabled finance capabilities when assessing valuation, and 57% cite AI and automation maturity as critical factors to a successful exit. Even if AI isn't central to the business, demonstrating data sophistication signals operational maturity.

Key question: Can you produce granular, consistent data on every KPI that matters to your equity story — customer-level economics, cohort analysis, unit economics — within 48 hours of a buyer requesting it?

How to Run Primary Research on Your Own Portfolio

This is where exit readiness moves from theory to practice — and where most PE firms leave value on the table.

You already know what buy-side due diligence looks like. You've sat through hundreds of expert calls, reviewed CDD reports, and challenged management teams on the other side of the table. The insight is simple: apply the same rigour to your own assets before a buyer does it for you.

Here are the four primary research workstreams that close the commercial readiness gap.

Customer health audit

What it is: An independent survey of 50–200 customers (depending on the base) to produce quantified metrics on satisfaction, retention likelihood, expansion willingness, competitive alternatives considered, and unmet needs.

Why it matters: A buyer's CDD advisor will run customer references. If those calls surface dissatisfaction, concentration risk, or switching intent that management hasn't disclosed, it's a valuation haircut — or worse, a broken process. Running this first means you control the narrative.

What to measure:

• Net Promoter Score (NPS) or equivalent satisfaction metric
• Likelihood to renew / expand spend over the next 12–24 months
• Competitive alternatives actively being evaluated
• Top three strengths and top three weaknesses, from the customer's perspective
• Willingness to serve as a buyer reference

How to use results: Positive findings become part of the equity story — hard numbers a buyer can't dismiss. Negative findings get flagged and addressed while you still have time, whether that's fixing a product gap, renegotiating a contract, or building the risk into your pricing expectations.

In one documented case cited by EY, early data readiness enabled a business to identify "at-risk" customers and reduce churn by 5%, combined with pricing optimisation on underperforming segments. Those two levers alone resulted in a 15% increase in EBITDA — and upon exit, the management team had an established fact base to build a stronger, more defensible equity story.

Competitive benchmarking calls

What it is: 10–15 expert interviews with competitors' executives, former employees, industry analysts, and sector specialists to build an objective competitive map.

Why it matters: Management teams naturally overstate differentiation. Competitors and industry observers give you the unvarnished view of where the asset is genuinely differentiated versus where the market sees commoditisation, pricing pressure, or emerging threats.

What to probe:

• How do competitors view this company's market position?
• Where is the company winning — and where is it losing — on product, price, and service?
• What competitive dynamics are shifting (new entrants, technology disruption, consolidation)?
• How defensible is the company's positioning over a 3–5 year horizon?

How to use results: Build an evidence-based competitive positioning slide that pre-empts the buyer's own benchmarking. If you know the company's weaknesses relative to peers, you can either address them operationally or build the narrative around them ("we're aware of X, here's our mitigation plan, and here's why Y and Z more than compensate").

Buyer-perspective expert interviews

What it is: 5–10 structured interviews with corporate development professionals, sector-focused PE investors, operating partners, and former CDD advisors to simulate what a buyer's due diligence process would surface.

Why it matters: These interviews identify the "killer questions" before they're asked in a live process. What would make a buyer pause? What risks would a CDD report flag? What's the first thing a strategic acquirer's integration team would worry about?

What to probe:

• If you were evaluating this asset, what would your top three diligence concerns be?
• What would you need to see to underwrite the growth story?
• What's the most common reason a deal like this breaks down in late-stage DD?
• How would you think about the multiple relative to comparable transactions?

How to use results: Build a "reverse DD checklist" — a document that maps every likely buyer concern to a pre-assembled evidence base. When a buyer's advisor asks the tough question, you have the answer ready with supporting data.

Market sizing validation & channel checks

What it is: Independent bottom-up market sizing through channel partner interviews, distributor checks, and industry expert conversations — not relying on the company's own TAM/SAM/SOM claims or top-down analyst reports.

Why it matters: Buyers scrutinise market sizing claims because they directly impact the growth narrative and implied penetration runway. If management says "we're 5% of a $10 billion market" and the buyer's research suggests it's a $4 billion market, the entire growth thesis collapses.

What to validate:

• Total addressable market, built bottom-up from channel data and expert input
• Current penetration rate, validated against independent sources
• End-market demand trends and growth drivers
• Pricing trends and elasticity

How to use results: Cross-reference management's growth narrative against independent customer and market data. Does the organic growth story hold up when you talk to actual customers and competitors? If yes, you have a bulletproof equity story. If not, you know exactly where it's vulnerable — and you can decide whether to fix the narrative or fix the business.

The Reverse DD Playbook: Think Like a Buyer

You've been on the buy side of the table. You know the playbook. Now flip it.

Here's a checklist of questions a buyer's CDD advisor will ask — and what you should have ready before they do.

The goal is simple: by the time a buyer's advisor picks up the phone to run diligence, you've already asked every question they will — and you have the answers documented, data-backed, and ready to present.

Firms that maintain this "always-on" readiness posture are 58% more likely to achieve faster diligence cycles, according to survey data from Accordion. Faster diligence means fewer opportunities for deal fatigue, fewer chances for competing priorities to derail the process, and higher probability of close.

Portfolio Triage: Prioritising Exits

With multiple portfolio companies to manage and limited bandwidth, deal teams need a framework for deciding which assets to prepare for exit first. Not every company in the portfolio is ready, and not every company should be pushed to market in the current window.

A practical triage framework considers three dimensions:

Tier 1: Exit now (next 6–12 months)

• Strong recent performance (revenue growth, margin expansion)
• Clear equity story with demonstrable value creation
• Market timing is favourable for the sector
• Fund life or LP expectations require near-term distributions

Action: Commission commercial DD immediately. Run customer surveys, competitive benchmarking, and buyer-perspective interviews within the next 60–90 days. Build the data-backed equity story.

Data supports this prioritisation: PE firms have been opting to sell their best-performing assets first — assets sold in 2024 and 2025 had median revenue growth two to three percentage points higher than assets remaining in the portfolio.

Tier 2: Prepare for exit (12–24 months)

• Solid fundamentals but gaps in the equity story
• Value creation initiatives underway but not yet fully reflected in financials
• Management team needs strengthening or the data infrastructure needs work

Action: Start commercial readiness assessment now. Use primary research findings to identify operational improvements — churn reduction, pricing optimisation, competitive repositioning — that can be executed during the remaining hold period. Treat primary research as a value-creation tool, not just DD validation.

Tier 3: Hold, restructure, or explore alternatives

• Underperforming relative to plan
• Market conditions unfavourable for the sector
• Significant operational or commercial issues that need 18+ months to resolve

Action: Consider continuation funds, partial sales, or dividend recaps as interim liquidity solutions. Use primary research to diagnose the root causes of underperformance — is it a market problem, a competitive problem, or an execution problem? The answer determines the path forward.

Timeline & Sequencing: What Can Be Achieved and When

Start earlier than you think. Close to half of PE firms begin exit readiness assessments 12–24 months in advance of sale. High-performing CFOs start more than 18 months ahead and are four times more likely to have prior exit experience.

Here's what a realistic timeline looks like for the commercial readiness dimension:

18+ months before exit: Ideal start

• Full customer health audit (survey + interviews)
• Comprehensive competitive benchmarking
• Market sizing validation
• Identify and execute on operational improvements surfaced by research
• Build data infrastructure to track relevant KPIs
• Conduct follow-up research to measure improvement

12 months before exit: Strong position

• Focused customer survey (key accounts + representative sample)
• Targeted competitive benchmarking (8–12 expert calls)
• Buyer-perspective interviews (5–8 calls)
• Address top issues identified by research
• Begin assembling the data-backed equity story

6 months before exit: Minimum viable preparation

• Rapid customer pulse survey (25–50 respondents)
• Focused competitive benchmarking (5–8 expert calls)
• 3–5 buyer-perspective interviews to identify likely DD concerns
• Build the reverse DD checklist and pre-assemble evidence
• Limited time to address operational gaps — focus on narrative and risk mitigation

Less than 6 months: Damage control

You can still run targeted primary research to identify and pre-empt the biggest DD risks, but you won't have time to fix underlying issues. At this stage, the research is purely about controlling the narrative and avoiding surprises — which still has real value, but you're leaving money on the table compared to starting earlier.

Remember: sponsors report that late exit preparation can reduce valuation by 1–3 turns of exit multiple. On a $200 million EBITDA business at 12x, that's $200–600 million of enterprise value at risk. The cost of running primary research 12–18 months early is a rounding error by comparison.

Building the Data-Backed Equity Story

The equity story is the connective tissue between what you've built and what a buyer is willing to pay for. In a market where sellers are competing for buyer attention and diligence standards are higher than ever, the quality of that narrative — and the evidence behind it — directly impacts outcomes.

Here's how to assemble primary research findings into a compelling, defensible equity story:

Lead with independently validated proof points

Instead of "management reports strong customer satisfaction," present "an independent survey of 150 customers shows an NPS of 62, with 87% expressing intent to renew and 41% planning to expand spend in the next 12 months." One is a claim. The other is evidence.

Address risks before the buyer raises them

If your competitive benchmarking surfaced a vulnerability — say, a new entrant gaining traction in one segment — don't hide it. Present the finding alongside your mitigation strategy. Sophisticated buyers respect transparency and distrust narratives that are too clean.

Quantify value creation with external validation

If you've improved pricing, validate the improvement through customer willingness-to-pay data. If you've expanded into a new market, confirm penetration through channel checks. If you've improved retention, show the before-and-after with independently measured metrics. This is what closes the gap that 65% of firms struggle with — capturing value creation initiatives in a way that buyers trust.

Compress diligence timelines

When you've already done the commercial DD a buyer would commission, you can offer them the findings proactively — or at minimum, you can respond to their DD requests with pre-assembled, evidence-backed answers in days rather than weeks. This builds buyer confidence, reduces deal fatigue, and shortens the path to close.

The Bottom Line

The 2026 exit market will reward preparation and punish complacency. With 11,000+ portfolio companies held for over five years, thousands of sponsors are going to be competing for buyer attention simultaneously. The assets that trade at strong multiples won't just be the best businesses — they'll be the best-evidenced ones.

Financial readiness gets you to the starting line. Operational readiness keeps you in the race. But commercial readiness — independently validated customer health, competitive positioning, revenue quality, and market dynamics — is what separates the assets that command premium multiples from the ones that stall in diligence.

The playbook is straightforward:

1. Flip the lens. Diligence your own portfolio with the same rigour you'd apply to a buy-side target.
2. Run the primary research. Customer surveys, competitive benchmarking, buyer-perspective interviews, and channel checks — done independently, not by management.
3. Start early. Twelve to eighteen months before exit gives you time to act on findings. Six months gives you time to control the narrative. Less than six months gives you damage control.
4. Build the evidence base. Assemble findings into a data-backed equity story that withstands buyer DD scrutiny and compresses diligence timelines.

The firms that treat exit readiness as a continuous, evidence-backed discipline — not a last-minute scramble — will be the ones that deliver the exits their LPs are waiting for.

If you're preparing a portfolio company for exit and want to run primary research to stress-test the commercial thesis, we should talk. Woozle runs customer surveys, competitive benchmarking, and buyer-perspective expert interviews as a done-for-you service — so your deal team gets the evidence without doing the fieldwork.